Nalpropion Pharmaceuticals

Patent cliffs & loss of exclusivity

Nalpropion Pharmaceuticals is a biopharmaceutical company focused on developing weight loss treatments.

Company

LinkedIn URLhttps://www.linkedin.com/company/nalpropion/
Official Websitehttps://www.nalpropion.com/

1 upcoming patent cliff

DrugIngredientTypeCliff
  1. CONTRAVEBUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDESmall mol.Jul 2034

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.